HMOX1 and Alzheimer disease: Furthermore, it was revealed in our previous study [13] that MAPKs play a critical role in IOE-mediated anti-AD effects, so we considered that MAPK pathways could be involved in IOE-mediated anti-neurodegenerative processes that control the expression of HO-1.